Psoriasis: A systemic disease;Psoriasis: Une maladie systémique

Presse Medicale

Volumn 41, Issue 4, 2012, Pages 338-348

  Bens, Guido ^a   Maccari, François ^b   Estève, Éric ^a  

^a CENTRE HOSPITALIER RÉGIONAL D ORLÉANS   (France)

^b SERVICE D ENDOCRINOLOGIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADDICTION; ATHEROSCLEROTIC PLAQUE; CLINICAL FEATURE; COMORBIDITY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENDOTHELIAL DYSFUNCTION; HUMAN; IMMUNOPATHOLOGY; INFLAMMATORY DISEASE; MENTAL STRESS; METABOLIC SYNDROME X; PATHOPHYSIOLOGY; PSORIASIS; PSYCHOPATHY; RISK FACTOR; SHORT SURVEY; SYSTEMIC DISEASE; ATHEROSCLEROSIS; COOPERATION; GENETIC PREDISPOSITION; HEALTH BEHAVIOR; INTERDISCIPLINARY COMMUNICATION; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATIENT ATTITUDE; PATIENT CARE; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; REVIEW; SOCIAL ENVIRONMENT; VASCULAR ENDOTHELIUM;

ATHEROSCLEROSIS; COMBINED MODALITY THERAPY; COMORBIDITY; COOPERATIVE BEHAVIOR; ENDOTHELIUM, VASCULAR; GENETIC PREDISPOSITION TO DISEASE; HEALTH BEHAVIOR; HUMANS; INTERDISCIPLINARY COMMUNICATION; METABOLIC SYNDROME X; MIDDLE AGED; PATIENT CARE TEAM; PSORIASIS; QUALITY OF LIFE; RISK FACTORS; SICK ROLE; SOCIAL ENVIRONMENT;

EID: 84858747670     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lpm.2011.09.026     Document Type: Short Survey

References (30)

1. Nestle F.O., Kaplan D.H., Barker J. Psoriasis. N Engl J Med 2009, 361:496-509.
2. Albanesi C., Scarponi C., Bosisio D., Sozzani S., Girolomoni G. Immune functions and recruitment of plasmacytoid dendritic cells in psoriasis. Autoimmunity 2010, 43:215-219.
3. Lande R., Gregorio J., Facchinetti V., Chatterjee B., Wang Y.H., Homey B., et al. Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature 2007, 449:564-569.
4. Gelfand J.M., Neimann A.L., Shin D.B., Wang X., Margolis D.J., Troxel A.B. Risk of myocardial infarction in patients with psoriasis. JAMA 2006, 296:1735-1741.
5. Kurd S.K., Troxel A.B., Crits-Christoph P., Gelfand J.M. The risk of depression, anxiety, and suicidality in patients with psoriasis: a population-based cohort study. Arch Dermatol 2010, 146:891-895.
6. Farkas A., Kemény L. Psoriasis and alcohol: is cutaneous ethanol one of the missing links?. Br J Dermatol 2010, 162:711-716.
7. Attwa E., Swelam E. Relationship between smoking-induced oxidative stress and the clinical severity of psoriasis. J Eur Acad Dermatol Venereol 2011, 25:782-787.
8. Balci D.D., Balci A., Karazincir S., Ucar E., Iyigun U., Yalcin F., et al. Increased carotid artery intima-media thickness and impaired endothelial function in psoriasis. J Eur Acad Dermatol Venereol 2009, 23:1-6.
9. Ludwig R.J., Herzog C., Rostock A., Ochsendorf F.R., Zollner T.M., Thaçi D., et al. Psoriasis: a possible risk factor for development of coronary artery calcification. Br J Dermatol 2007, 156:271-276.
10. Späh F. Inflammation in atherosclerosis and psoriasis: common pathogenic mechanisms and the potential for an integrated treatment approach. Br J Dermatol 2008, 159(Suppl. 2):10-17.
11. Boehncke W.H., Boehncke S., Tobin A.M., Kirby B. The 'psoriatic march': a concept of how severe psoriasis may drive cardiovascular comorbidity. Exp Dermatol 2011, 20:303-307.
12. Boehncke S., Thaçi D., Beschmann H., Ludwig R.J., Ackermann H., Badenhoop K., et al. Psoariasis patients show signs of insulin resistance. Br J Dermatol 2007, 157:1249-1251.
13. Gisondi P., Del Giglio M., Di Francesco V., Zamboni M., Girolomoni G. Weight loss improves the response of obese patients with moderate to severe chronic plaque psoriasis to low-dose cyclosporine therapy: a randomized, controlled, investigator-blinded clinical trial. Am J Clin Nutr 2008, 88:1242-1247.
14. Sommer D.M., Jenisch S., Suchan M., Christophers E., Weichenthal M. Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis. Arch Dermatol Res 2006, 298:321-328.
15. Hotamisligil G.S. Inflammation and metabolic disorders. Nature 2006, 444:860-867.
16. Davidovici B.B., Sattar N., Prinz J.C., Puig L., Emery P., Barker J.N., et al. Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions. J Invest Dermatol 2010, 130:1785-1796.
17. Dubertret L., Mrowietz U., Ranki A., van de Kerkhof P.C., Chimenti S., Lotti T., et al. European patient perspectives on the impact of psoriasis: the EUROPSO patient membership survey. Br J Dermatol 2006, 155:729-736.
18. Goulding J.M., Price C.L., Defty C.L., Hulangamuwa C.S., Bader E., Ahmed I. Erectile dysfunction in patients with psoriasis: increased prevalence, an unmet need, and a chance to intervene. Br J Dermatol 2011, 164:103-109.
19. Boehncke S., Salgo R., Garbaraviciene J., Beschmann H., Hardt K., Diehl S., et al. Effective continuous systemic therapy of severe plaque-type psoriasis is accompanied by amelioration of biomarkers of cardiovascular risk: results of a prospective longitudinal oberservational study. J Eur Acad Dermatol Venereol 2011, 25:1187-1193.
20. Prodanowich S., Ma F., Taylor J.R., Pezon C., Fasihi T., Kirsner R.S. Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritis. J Am Acad Dermatol 2005, 52:262-267.
21. Wu JJ. The effect of tumor necrosis factor-alpha inhibitors on the risk of myocardial infarction in patients with psoriasis. Poster No. 400, 69th Annual Meeting of the American Academy of Dermatology, New Orleans; 2011.
22. Abuabara K., Lee H., Kimball A.B. The effect of systemic psoriasis therapies on the incidence of myocardial infarction: a cohort study. Br J Dermatol 2011, 165:1066-1073.
23. Cohen A.D., Dreiher J., Birkenfeld S. Psoriasis associated with ulcerative colitis and Crohn's disease. J Eur Acad Dermatol Venereol 2009, 23:561-565.
24. Schmitt J., Ford D.E. Psoriasis is independently associated with psychiatric morbidity and adverse cardiovascular risk factors, but not with cardiovascular events in a population-based sample. J Eur Acad Dermatol Venereol 2010, 24:885-892.
25. Prey S., Paul C., Bronsard V., Puzenat E., Gourraud P.A., Aractingi S., et al. Cardiovascular risk factors in patients with plaque psoriasis: a systematic revue of epidemiological studies. J Eur Acad Dermatol 2010, 24(Suppl. 2):23-30.
26. Wakkee M., Herings R.M., Nijsten T. Psoriasis may not be an independent risk factor for acute ischemic heart disease hospitalizations: results of a large population-based Dutch cohort. J Invest Dermatol 2010, 130:962-967.
27. Gelfand J.M., Dommasch E.D., Shin D.B., Azfar R.S., Kurd S.K., Wang X. The risk of stroke in patients with psoriasis. J Invest Dermatol 2009, 129:2411-2418.
28. Miele L., Vallone S., Cefalo C., La Torre G., Di Stasi C., Vecchio F.M., et al. Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis. J Hepatol 2009, 51:778-786.
29. Gelfand J.M., Shin D.B., Neimann A.L., Wang X., Margolis D.J., Troxel A.B. The risk of lymphoma in patients with psoriasis. J Invest Dermatol 2006, 126:2194-2201.
30. Stern R.S. Lymphoma risk in psoriasis. Arch Dermatol 2006, 142:1132-1135.